NCT04220437

Brief Summary

Based on the large population of patients, in-stent restenosis (ISR) is still an important problem in the field of cardiovascular disease. How to reduce the incidence of ISR and the treatment of ISR has become the focus and hot spot. The 2018 ESC Guidelines for Cardiovascular Intervention recommends treatment of ISR under the guidance of intravascular ultrasound (IVUS), or optical coherent tomography (OCT). Circulation published a new Waksman ISR classification based on mechanisms and components of the restenosis tissue, which provides guidance for treatment strategy. Because of its good resolution, OCT makes it more accurate to distinguish the components of vascular tissue, thus providing a decision-making basis for interventional therapy. OCT examination can obtain the characteristics of the ISR more precisely. Neoatherosclerosis (NA), is one of the ISR types and accounts for more stent failure and target lesion failure than other types. Identification NA is important for decision-making of interventional therapy. However, the acquisition and analysis of OCT images not only need the digital angiography machine (DSA) equipped with the majority of hospitals, but also need professional OCT imaging equipment and technicians. Patients with severely CKD cannot bear OCT examination because of the large amount of contrast agent. OCT catheter is more than ten times the price of the CAG catheter. Therefore, identification of NA by the use of artificial intelligence (AI) is of significance to set therapeutic strategy for ISR patients, especially in patients with CKD. Our study retrospectively analyzed CAG images and OCT images of ISR patients obtained from Jan 1st,2015 to Oct 31st,2020. Identify NA by analyzing OCT images, build up U-net and V-net to analyze the CAG and OCT images, and finally build up an identification system of NA based on CAG images by AI. This study has been approved by Ethics Committee of Chinese PLA General Hospital (S2018-033-01)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
4.9 years until next milestone

First Submitted

Initial submission to the registry

December 21, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 7, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

January 15, 2021

Status Verified

January 1, 2021

Enrollment Period

6 years

First QC Date

December 21, 2019

Last Update Submit

January 13, 2021

Conditions

Keywords

Neoatherosclerosisin-stent restenosisOptical Coherence Tomographyangiographyartificial intelligence

Outcome Measures

Primary Outcomes (6)

  • The identification of NA

    a neointima containing a diffuse border and a signal-poor region, with the struts underneath invisible because of the marked signal attenuation

    through the study completion, an average of 3 years

  • neovascularizaion

    diameter 50-300um, cavity in the stent area, not connected with the vasular

    through the study completion, an average of 3 years

  • ISR segment in the CAG images

    the segement in the stent area or within 5mm beside the stent,diameter stenosis rate\>50%

    through the study completion, an average of 3 years

  • lipid-core arc

    To quantify the circumferential extent of NA, the lipid-core arc was measured at a 0.2-mm interval throughout the segments showing NA.

    through the study completion, an average of 3 years

  • Thin-cap fibroatheroma-like neointima

    defined as a neointima characterized by a fibrous cap thickness at the thinnest part of \<65 μm and an angle of lipid-laden neointima of \>180 degrees

    through the study completion, an average of 3 years

  • macrophage arc

    measured at 0.2-mm intervals and divided into 5 groups: grade 0, no macrophages; grade 1, localized macrophage accumulation, \<30 degrees; grade 2, clustered accumulation, ≥30 and \<90 degrees; grade 3, clustered accumulation, ≥90 and \<270 degrees; and grade 4, clustered accumulation, ≥270 degrees.

    through the study completion, an average of 3 years

Study Arms (1)

CAG and OCT group

Images of CAG and OCT patients obtained from ISR patients were retrospectively collected and analyzed.

Other: no interventin

Interventions

Our stusy analysed the images obtained from ISR patients, no extra intervention was given based on this study.

CAG and OCT group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

100 patients were enrolled

You may qualify if:

  • \- all gender
  • ys old to 80ys old
  • diagnosed of in-stent restenosis based on CAG
  • both CAG images and OCT images were obtained in the same patient on the same day

You may not qualify if:

  • CAG images and OCT images were not obtained on the same day in the same patient
  • low quality in CAG images
  • low qualitiy in OCT images

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The General Hospital of PLA

Beijing, 100853, China

RECRUITING

Study Officials

  • Yundai Chen, M.D

    Chinese PLA General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yingqian Zhang, M.D

CONTACT

Hui Hui, PH.D

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 21, 2019

First Posted

January 7, 2020

Study Start

February 1, 2015

Primary Completion

January 31, 2021

Study Completion

February 28, 2021

Last Updated

January 15, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations